Home Applications 205544 Application 205544
Type ANDA
Sponsor WILSHIRE PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NATEGLINIDE NATEGLINIDE TABLET;ORAL 60MG No No 002 NATEGLINIDE NATEGLINIDE TABLET;ORAL 120MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A205544-001 NATEGLINIDE NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 A205544-002 NATEGLINIDE NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A205544-001 NATEGLINIDE 60MG TABLET / ORAL AB 2018-06-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A205544-002 NATEGLINIDE 120MG TABLET / ORAL AB 2018-06-18 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 16571-758 NATEGLINIDE NATEGLINIDE Rising Pharmaceuticals, Inc. ANDA Current 16571-758 NATEGLINIDE NATEGLINIDE Rising Pharma Holdings, Inc. ANDA Current 16571-759 NATEGLINIDE NATEGLINIDE Rising Pharmaceuticals, Inc. ANDA Current 16571-759 NATEGLINIDE NATEGLINIDE Rising Pharma Holdings, Inc. ANDA Current 52536-063 Nateglinide Nateglinide Wilshire Pharmaceuticals, Inc. ANDA Current 52536-067 Nateglinide Nateglinide Wilshire Pharmaceuticals, Inc. ANDA Current